Epsilon Imaging is a medical device company focused on enabling clinicians to improve cardiovascular patient management and outcomes with echocardiographic speckle tracking strain imaging via its innovative EchoInsight®visualization and analysis software. EchoInsight, an FDA-approved software platform, provides echo labs and their hospital networks with an efficient software solution to incorporate the valuable benefits of echo strain imaging into routine clinical practice. Strain imaging has proven to be more predictive and less variable than traditional gold standard measurements for assessing and monitoring the heart with echo. Strain imaging is a recommended measurement for assessment and monitoring of echo by the American Society of Echocardiography (ASE) and other societies, and there is also a reimbursable CPT code in the United States.
EchoInsight aids clinicians in easily adding the benefits of strain imaging while streamlining analysis, interpretation, and monitoring of echocardiography studies. As a unique strain imaging software with its vendor neutral, offline, and zero footprint platform, EchoInsight provides validated strain imaging and automation of cardiac function measurements based on ASE guidelines. Epsilon Imaging provides a suite of EchoInsight applications that include LV, LV Contrast, RV, Full Heart, and Stress Echo, and can easily scale based on customer echo volumes, economics, and needs. Today, EchoInsight is used by clinical echo labs and hospitals, along with Academic Research Organizations and Core Labs.
Founded in 2008, Epsilon Imaging’s technology was invented at the University of Michigan, in the Biomedical Engineering Department. Epsilon Imaging is a privately held company.